Hunt Holdings Limited Partnership

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2021-01-26	2021-01-25	Exagen Inc (XGN)	S Sale	28,021 -2.2% 16.01 USD 448,616	28,021 -2.2%	16.01	USD 448,616
2021-01-26	2021-01-22	Exagen Inc (XGN)	S Sale	23,646 -1.8% 16.07 USD 379,991	23,646 -1.8%	16.07	USD 379,991
2021-01-21	2021-01-21	Exagen Inc (XGN)	S Sale	50,000 -3.7% 16.01 USD 800,700	50,000 -3.7%	16.01	USD 800,700
2021-01-21	2021-01-20	Exagen Inc (XGN)	S Sale	30,000 -2.2% 16.13 USD 483,990	30,000 -2.2%	16.13	USD 483,990
2021-01-21	2021-01-19	Exagen Inc (XGN)	S Sale	30,000 -2.1% 16.00 USD 480,048	30,000 -2.1%	16.00	USD 480,048
2021-01-14	2021-01-12	Exagen Inc (XGN)	S Sale	15,000 -1.0% 16.04 USD 240,584	15,000 -1.0%	16.04	USD 240,584
2021-01-11	2021-01-11	Exagen Inc (XGN)	S Sale	7,394 -0.5% 16.03 USD 118,526	7,394 -0.5%	16.03	USD 118,526
2021-01-11	2021-01-08	Exagen Inc (XGN)	S Sale	15,186 -1.0% 16.07 USD 244,039	15,186 -1.0%	16.07	USD 244,039
2021-01-11	2021-01-07	Exagen Inc (XGN)	S Sale	10,000 -0.7% 16.04 USD 160,400	10,000 -0.7%	16.04	USD 160,400
2020-11-12	2020-11-11	Exagen Inc (XGN)	S Sale	150 -0.0% 16.00 USD 2,400	150 -0.0%	16.00	USD 2,400
2020-11-12	2020-11-10	Exagen Inc (XGN)	S Sale	9,045 -0.6% 16.06 USD 145,263	9,045 -0.6%	16.06	USD 145,263
2020-11-12	2020-11-09	Exagen Inc (XGN)	S Sale	6,752 -0.5% 16.04 USD 108,302	6,752 -0.5%	16.04	USD 108,302